Fulltext

Concurrent and simultaneous polydrug use among young Swiss males: use patterns and associations of number of substances used with health issues

Baggio, Stéphanie ; Studer, Joseph ; Mohler-Kuo, Meichun ; Daeppen, Jean-Bernard ; Gmel, Gerhard

In: International Journal of Adolescent Medicine and Health, 2014, vol. 26, no. 2, p. 217-224

Ajouter à la liste personnelle
    Titre
    • Concurrent and simultaneous polydrug use among young Swiss males: use patterns and associations of number of substances used with health issues
    Auteur
    • Baggio, Stéphanie. Alcohol Treatment Center, Lausanne University Hospital, Lausanne, Switzerland
    • Studer, Joseph. Alcohol Treatment Center, Lausanne University Hospital, Lausanne, Switzerland
    • Mohler-Kuo, Meichun. Institute of Social- and Preventive Medicine, University of Zurich, Zurich, Switzerland
    • Daeppen, Jean-Bernard. Alcohol Treatment Center, Lausanne University Hospital, Lausanne, Switzerland
    • Gmel, Gerhard
    Type de document
    • Postprint
    Langue
    • Anglais
    Publié dans
    • International Journal of Adolescent Medicine and Health, 2014, vol. 26, no. 2, p. 217-224. De Gruyter
    Autre version électronique
    Identifiant OAI-PMH
    • oai:doc.rero.ch:295493
    Summary
    Background: Simultaneous polydrug use (SPU) may represent a greater incremental risk factor for human health than concurrent polydrug use (CPU). However, few studies have examined these patterns of use in relation to health issues, particularly with regard to the number of drugs used. Methods: In the present study, we have analyzed data from a representative sample of 5734 young Swiss males from the Cohort Study on Substance Use Risk Factors. Exposure to drugs (i.e., alcohol, tobacco, cannabis, and 15 other illicit drugs), as well as mental, social and physical factors, were studied through regression analysis. Results: We found that individuals engaging in CPU and SPU followed the known stages of drug use, involving initial experiences with licit drugs (e.g., alcohol and tobacco), followed by use of cannabis and then other illicit drugs. In this regard, two classes of illicit drugs were identified, including first uppers, hallucinogens and sniffed drugs; and then "harder” drugs (ketamine, heroin, and crystal meth), which were only consumed by polydrug users who were already taking numerous drugs. Moreover, we observed an association between the number of drugs used simultaneously and social issues (i.e., social consequences and aggressiveness). In fact, the more often the participants simultaneously used substances, the more likely they were to experience social problems. In contrast, we did not find any relationship between SPU and depression, anxiety, health consequences, or health. Conclusions: We identified some associations with SPU that were independent of CPU. Moreover, we found that the number of concurrently used drugs can be a strong factor associated with mental and physical health, although their simultaneous use may not significantly contribute to this association. Finally, the negative effects related to the use of one substance might be counteracted by the use of an additional substance